
Nutrien Ltd NTR.TO is expected to show a rise in quarterly revenue when it reports results on May 7 for the period ending March 31 2025
The Saskatoon Saskatchewan-based company is expected to report a 0.6% increase in revenue to $5.184 billion from $5.15 billion a year ago, according to the mean estimate from 10 analysts, based on LSEG data. (Sales is on Net Revenue)
LSEG's mean analyst estimate for Nutrien Ltd is for earnings of 31 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy," 6 "hold" and 2 "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.
Wall Street's median 12-month price target for Nutrien Ltd is $60.00, below its last closing price of C$78.51.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | 0.38 | 0.35 | 0.31 | Missed | -10.9 |
Sep. 30 2024 | 0.46 | 0.46 | 0.39 | Missed | -15.3 |
Jun. 30 2024 | 2.20 | 2.21 | 2.34 | Beat | 5.8 |
Mar. 31 2024 | 0.38 | 0.39 | 0.46 | Beat | 19.4 |
Dec. 31 2023 | 0.65 | 0.65 | 0.37 | Missed | -43.5 |
Sep. 30 2023 | 0.58 | 0.64 | 0.35 | Missed | -45.6 |
Jun. 30 2023 | 2.76 | 2.77 | 2.53 | Missed | -8.6 |
Mar. 31 2023 | 1.47 | 1.50 | 1.11 | Missed | -25.8 |
This summary was machine generated May 5 at 20:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)